ClinConnect ClinConnect Logo
Search / Trial NCT06852859

Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia

Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Feb 27, 2025

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how men recover after surgery for benign prostatic hyperplasia (BPH), a condition that causes an enlarged prostate. The study will track patients for three months after their surgery to understand their experiences with pain, any burning sensations, urinary leakage, and the use of pain medications. It will compare results from three different surgical techniques: transurethral resection, transurethral vaporization, and laser surgery. The goal is to see how these methods affect recovery and how long it takes for patients to feel better.

To participate in this study, men aged 18 and older who are planning to have surgery for BPH can sign up, provided they can speak Swedish. Participants will share their experiences and symptoms during the recovery period, helping researchers understand how different surgical options impact recovery. It's an important opportunity to contribute to knowledge that could improve care for future patients facing similar surgeries.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing transurethral surgery for benign prostatic hyperplasia
  • Singed informed consent to participate
  • Exclusion Criteria:
  • Non-swedish speaking patients

About Sahlgrenska University Hospital

Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.

Locations

Alingsås, , Sweden

Kungälv, , Sweden

Uddevalla, , Sweden

Patients applied

0 patients applied

Trial Officials

Joakim BE Strömberg, MD, PhD

Principal Investigator

Sahlgrenska University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported